Suchergebnisse - "Pinato, David J"

PubPharm (6)

1

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

enthalten in: Journal of hepatology | 2024

von Celsa, C. | Cabibbo, G. | Fulgenzi, C. | +69

2

Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer

enthalten in: BJU international | 2022

von Makrakis, D. | Talukder, R. | Diamantopoulos, L. | +44

3

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma : a comparison of outcomes

enthalten in: BJU international | 2021

von Esagian, S. | Khaki, A. | Diamantopoulos, L. | +43

4

Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab

enthalten in: Journal for immunotherapy of cancer | 2021

von Alexander, J. | Ibraheim, H. | Sheth, B. | +20

5

Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis

enthalten in: Journal of hepatology | 2021

von Gudd, C. | Au, L. | Triantafyllou, E. | +17

6

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

enthalten in: Journal for immunotherapy of cancer | 2021

von Cortellini, A. | Di Maio, M. | Nigro, O. | +58

1
[1]